Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-33,258
Closed -$3.84M 374
2023
Q2
$3.84M Sell
33,258
-161,708
-83% -$18.4M 0.02% 318
2023
Q1
$20.7M Buy
194,966
+107,282
+122% +$11.6M 0.08% 101
2022
Q4
$9.73M Sell
87,684
-25,305
-22% -$2.59M 0.04% 156
2022
Q3
$9.73M Buy
112,989
+53,642
+90% +$4.79M 0.04% 164
2022
Q2
$5.41M Buy
+59,347
New +$5.26M 0.02% 238
2021
Q4
Sell
-159,192
Closed -$12M 704
2021
Q3
$12M Buy
+159,192
New +$12.1M 0.05% 120
2014
Q1
Sell
-46,322
Closed -$2.21M 178
2013
Q4
$2.21M Hold
46,322
0.01% 120
2013
Q3
$2.1M Hold
46,322
0.01% 124
2013
Q2
$2.05M Buy
+46,322
New +$2.07M 0.01% 126

Other funds holding MRK

Brookfield Corp's MRK Position: Q3 2023 in Review

Brookfield Corp sold out of Merck (MRK) in Q3 2023, closing a stake of 33,258 shares — an estimated $3.84M sold.

Brookfield Corp first reported a position in MRK in Q2 2013 and held it in 9 quarters. The position peaked at $20.7M in Q1 2023. 3,215 funds tracked by Wall St. Rank hold MRK as of Q3 2023.

  • Brookfield Corp reported no remaining Merck position as of Q3 2023 after selling out during the quarter.
  • Brookfield Corp sold 33,258 Merck shares in Q3 2023, an estimated $3.84M.
  • Brookfield Corp first reported a position in Merck in Q2 2013 and held it in 9 quarters.
  • Brookfield Corp's Merck position peaked at $20.7M in Q1 2023.
  • 3,215 funds tracked by Wall St. Rank held Merck as of Q3 2023.

Based on Brookfield Corp's 13F filing for Q3 2023, filed 14 Nov 2023.